- Home
- NXST vs XENE Comparison
NXST vs XENE Comparison
Compare NXST & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXST | XENE |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.9B |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NXST | XENE |
|---|---|---|
| Price | $176.83 | $59.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $263.75 | $68.55 |
| AVG Volume (30 Days) | 274.6K | ★ 619.9K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.71 | N/A |
| Revenue | ★ $4,949,000,000.00 | $311,000.00 |
| Revenue This Year | $11.38 | N/A |
| Revenue Next Year | N/A | $2,496.48 |
| P/E Ratio | $20.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $154.47 | $35.60 |
| 52 Week High | $254.30 | $72.66 |
Technical Indicators
Market Signals| Indicator | NXST | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 43.69 |
| Support Level | $176.41 | $52.40 |
| Resistance Level | $190.97 | $62.91 |
| Average True Range (ATR) | 5.71 | 2.20 |
| MACD | -1.29 | -0.22 |
| Stochastic Oscillator | 15.84 | 17.95 |
Price Performance
Historical ComparisonAbout NXST Nexstar Media Group Inc.
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.